Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant Schizophrenia
出版年份 2015 全文链接
标题
Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant Schizophrenia
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 16, Issue 12, Pages 30144-30163
出版商
MDPI AG
发表日期
2015-12-17
DOI
10.3390/ijms161226228
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Rate and predictors of non-response to first-line antipsychotic treatment in first-episode schizophrenia
- (2015) Bonginkosi Chiliza et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- G protein-coupled receptor kinase 6/β-arrestin 2 system in a rat model of dopamine supersensitivity psychosis
- (2015) Yasunori Oda et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Dopamine supersensitivity psychosis and dopamine partial agonist: A retrospective survey of failure of switching to aripiprazole in schizophrenia
- (2015) Masayuki Takase et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia
- (2015) Tomotaka Suzuki et al. PSYCHIATRY RESEARCH
- Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice
- (2014) Raquel Gomez-Sintes et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Increased G protein-coupled receptor kinase (GRK) expression in the anterior cingulate cortex in schizophrenia
- (2014) Adam J. Funk et al. SCHIZOPHRENIA RESEARCH
- A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosis
- (2014) Hiroshi Kimura et al. SCHIZOPHRENIA RESEARCH
- Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia
- (2013) Arsime Demjaha et al. AMERICAN JOURNAL OF PSYCHIATRY
- Association ofGSK-3βGenetic Variation With GSK-3β Expression, Prefrontal Cortical Thickness, Prefrontal Physiology, and Schizophrenia
- (2013) Giuseppe Blasi et al. AMERICAN JOURNAL OF PSYCHIATRY
- Glycogen Synthase Kinase-3 Overexpression Replicates Electroretinogram Anomalies of Offspring at High Genetic Risk for Schizophrenia and Bipolar Disorder
- (2013) Joëlle Lavoie et al. BIOLOGICAL PSYCHIATRY
- Association study of common variants within the G protein-coupled receptor kinase 6 gene and schizophrenia susceptibility in Han Chinese
- (2013) Wenxin Tang et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Optimal Extent of Dopamine D2 Receptor Occupancy by Antipsychotics for Treatment of Dopamine Supersensitivity Psychosis and Late-Onset Psychosis
- (2013) Masaomi Iyo et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- GSK-3β Polymorphism Discriminates Bipolar Disorder and Schizophrenia: A Systematic Meta-Analysis
- (2013) Hui Tang et al. MOLECULAR NEUROBIOLOGY
- Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression
- (2013) Y Kunii et al. MOLECULAR PSYCHIATRY
- Altered GSK3β signaling in an infection-based mouse model of developmental neuropsychiatric disease
- (2013) Roman Willi et al. NEUROPHARMACOLOGY
- Are dopamine D2 receptors out of control in psychosis?
- (2013) Philip Seeman PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- No association between AKT1 gene variants and schizophrenia: A Malaysian case-control study and meta-analysis
- (2013) Han Chern Loh et al. PSYCHIATRY RESEARCH
- Electrophysiological and behavioral responses to ketamine in mice with reduced Akt1 expression
- (2013) Robert E. Featherstone et al. PSYCHOPHARMACOLOGY
- The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
- (2012) Oliver D. Howes et al. ARCHIVES OF GENERAL PSYCHIATRY
- Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis Users
- (2012) Marta Di Forti et al. BIOLOGICAL PSYCHIATRY
- The possible role of the Akt signaling pathway in schizophrenia
- (2012) Wenhua Zheng et al. BRAIN RESEARCH
- Inhibition of glycogen synthase kinase-3 attenuates psychotomimetic effects of ketamine
- (2012) Ming-Huan Chan et al. SCHIZOPHRENIA RESEARCH
- AKT/GSK3 signaling pathway and schizophrenia
- (2012) Effat S. Emamian Frontiers in Molecular Neuroscience
- Hypothesis review: are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder?
- (2011) K O Schubert et al. MOLECULAR PSYCHIATRY
- Reduced expression of G protein-coupled receptor kinases in schizophrenia but not in schizoaffective disorder
- (2011) E.R. Bychkov et al. NEUROBIOLOGY OF DISEASE
- CALM, A Clathrin Assembly Protein, Influences Cell Surface GluR2 Abundance
- (2011) Asaff Harel et al. NEUROMOLECULAR MEDICINE
- AKT1 Moderation of Cannabis-Induced Cognitive Alterations in Psychotic Disorder
- (2011) Ruud van Winkel et al. NEUROPSYCHOPHARMACOLOGY
- The Physiology, Signaling, and Pharmacology of Dopamine Receptors
- (2011) J.-M. Beaulieu et al. PHARMACOLOGICAL REVIEWS
- Discovery of -Arrestin-Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy
- (2011) J. A. Allen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chronic Treatment With Aripiprazole Prevents Development of Dopamine Supersensitivity and Potentially Supersensitivity Psychosis
- (2011) S. Tadokoro et al. SCHIZOPHRENIA BULLETIN
- Genetic association and identification of a functional SNP at GSK3β for schizophrenia susceptibility
- (2011) Ming Li et al. SCHIZOPHRENIA RESEARCH
- Cell membrane lytic action of metoclopramide and its relation to tardive dyskinesia
- (2011) Terence K.Y. Lai et al. SYNAPSE
- D2Receptor Genetic Variation and Clinical Response to Antipsychotic Drug Treatment: A Meta-Analysis
- (2010) Jian-Ping Zhang et al. AMERICAN JOURNAL OF PSYCHIATRY
- Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
- (2010) Lawrence S. Kegeles et al. ARCHIVES OF GENERAL PSYCHIATRY
- Reconnaître les symptômes psychiatriques iatrogènes liés aux antipsychotiques
- (2010) C. Demily et al. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE
- A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosis
- (2010) Paul Fallon et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Behavioral phenotyping of v-akt murine thymoma viral oncogene homolog 1-deficient mice reveals a sex-specific prepulse inhibition deficit in females that can be partially alleviated by glycogen synthase kinase-3 inhibitors but not by antipsychotics
- (2010) Y.W. Chen et al. NEUROSCIENCE
- GSK-3β activity and hyperdopamine-dependent behaviors
- (2010) Yan-Chun Li et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Lentiviral Overexpression of GRK6 Alleviates L-Dopa-Induced Dyskinesia in Experimental Parkinson's Disease
- (2010) M. R. Ahmed et al. Science Translational Medicine
- Antipsychotic drug binding in the substantia nigra: An examination of high metoclopramide binding in the brains of normal, Alzheimer's disease, Huntington's disease, and Multiple Sclerosis patients, and its relation to tardive dyskinesia
- (2010) Sheng Chen et al. SYNAPSE
- Roles of the Akt/GSK-3 and Wnt Signaling Pathways in Schizophrenia and Antipsychotic Drug Action
- (2009) Zachary Freyberg et al. AMERICAN JOURNAL OF PSYCHIATRY
- The Effect of Antipsychotics on the High-Affinity State of D2 and D3 Receptors
- (2009) Ariel Graff-Guerrero et al. ARCHIVES OF GENERAL PSYCHIATRY
- The coding-synonymous polymorphism rs1045280 (Ser280Ser) inβ-arrestin 2(ARRB2) gene is associated with tardive dyskinesia in Chinese patients with schizophrenia
- (2008) Y.-J. Liou et al. EUROPEAN JOURNAL OF NEUROLOGY
- The Dopamine D2 Receptors in High-Affinity State and D3 Receptors in Schizophrenia: A Clinical [11C]-(+)-PHNO PET Study
- (2008) Ariel Graff-Guerrero et al. NEUROPSYCHOPHARMACOLOGY
- Physiological and pharmacological implications of beta-arrestin regulation
- (2008) Cullen L. Schmid et al. PHARMACOLOGY & THERAPEUTICS
- Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response
- (2008) Renan P. Souza et al. PSYCHOPHARMACOLOGY
- Atypical Antipsychotics: CATIE Study, Drug-Induced Movement Disorder and Resulting Iatrogenic Psychiatric-Like Symptoms, Supersensitivity Rebound Psychosis and Withdrawal Discontinuation Syndromes
- (2008) Guy Chouinard et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Course of illness in a sample of 265 patients with first-episode psychosis—Five-year follow-up of the Danish OPUS trial
- (2008) Mette Bertelsen et al. SCHIZOPHRENIA RESEARCH
- Dopamine D2High receptors moderately elevated by sertindole
- (2008) Philip Seeman SYNAPSE
- AKT1 Is Associated with Schizophrenia Across Multiple Symptom Dimensions in the Irish Study of High Density Schizophrenia Families
- (2007) Dawn L. Thiselton et al. BIOLOGICAL PSYCHIATRY
- Genetic analysis of the gene coding for DARPP-32 (PPP1R1B) in Japanese patients with schizophrenia or bipolar disorder
- (2007) Akira Yoshimi et al. SCHIZOPHRENIA RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search